SG
GDRX icon

Stonnington Group’s GoodRx Holdings GDRX Stock Holding History

Stonnington Group’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$189K Buy
+30,500
New +$170K 0.05% 230

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stonnington Group's GDRX Position: Q1 2023 in Review

Stonnington Group opened a new position in GoodRx Holdings (GDRX) in Q1 2023: 30,500 shares worth $189K. The stake represents 0.05% of the portfolio and ranks #230 among its holdings.

159 funds tracked by Wall St. Rank hold GDRX as of Q1 2023.

  • Stonnington Group held 30,500 shares of GoodRx Holdings worth $189K as of Q1 2023.
  • GoodRx Holdings was a new Stonnington Group position in Q1 2023.
  • GoodRx Holdings made up 0.05% of Stonnington Group's portfolio in Q1 2023, its #230 holding.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.